logo-loader
Bushveld Minerals Limited

Bushveld Minerals snaps up vanadium processing plant in South Africa for US$68mln

“This substantially reduces the capital required to bring the Mokopane Project into production. "

steel making
Vanadium is used to strengthen steel

Bushveld Minerals Limited (LON: BMN) has doubled its vanadium processing capacity in South Africa with the acquisition of Vanchem for US$68mln.

Fortune Mojapelo, chief executive, said the deal cements Bushveld’s position as a leading global vanadium producer.

“We consider ourselves the ideal buyer for these businesses.” 

Vanchem’s processing plant is 200Km away from Bushveld’s own Mokopane project, which will be the primary source of ore.

Refurbishing the three kilns at the facility will cost an additional US$45mln and when finished will more than double Bushveld’s processing capacity to over 8,000mtV per year.

This takes Bushveld a substantial way towards its target of 10,000 mtV per year, added Mojapelo.

A further US$20mln is required to develop Mokopane.

“This highly strategic transaction combines our existing portfolio of high-grade low-cost primary vanadium resources, including the Mokopane greenfield deposit, with an established production facility,” said Mojapelo. 

“This substantially reduces the capital required to bring the Mokopane Project into production, while also bringing it online in a much shorter timeframe than if we were to construct a new plant. 

Vanchem’s three-kiln configuration gives its production flexibility, while its chemical products also complement the electrolytes for vanadium redox batteries being developed by Bushveld's battery arm.

“This chemical capability will be particularly key as the company grows its exposure to the emerging stationary energy storage industry," said Mojapelo.

Quick facts: Bushveld Minerals Limited

Price: £0.22

Market: LSE
Market Cap: £243.4 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bushveld Minerals Limited named herein, including the promotion by the Company of Bushveld Minerals Limited in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: hVIVO’s mosquito vaccine moves into the clinic

Headlines from the Proactive Investors UK newsroom.  Clinical services group hVIVO’s (LON:HVO) experimental vaccine AGS-v PLUS is to undergo a phase 1 safety trial at the University of Maryland school of medicine. The vaccine is designed to protect against mosquito-borne diseases such as...

on 31/7/19

2 min read